Malaria medicine box expands

Malaria medicine box expands, Published online: 01 October 2018; doi:10.1038/nrd.2018.156

With the FDA's approval of GlaxoSmithKline's tafenoquine, global health experts will at last have access to a long-awaited new treatment for Plasmodium vivax recurrence. Much-needed novel treatments for the more common Plasmodium falciparum are in phase II trials.

中文翻译：

---

疟疾药箱扩大

疟疾药箱扩大

疟疾药箱扩大，在线发布：2018年10月1日; doi：10.1038 / nrd.2018.156

有了FDA批准的葛兰素史克（GlaxoSmithKline）的tafenoquine，全球卫生专家将最终获得期待已久的间日疟原虫复发的新疗法。在II期临床试验中，对更常见的恶性疟原虫急需的新型治疗方法。